Read our newsletter for coverage of events, news, research highlights, grants, awards, and more in the Populations Sciences Research Program at MSK.

Current Issue

Read the October 2022 Newsletter

Back Issues

• Winter 2022
• July 2021
• March 2021
• Summer 2020
• May 2020
• November 2018
• August 2018
• November 2017
• June 2017
• November 2016
• September 2016
• May 2016
• March 2016
• January 2016
• November 2015
• September 2015
• May 2015
  Experts discuss challenges in triple-negative breast cancer; predicting late effects of cancer treatment; germline testing approved for MSK patients
• March 2015
  Skin cancer research at MSK addresses risk, behavior and survivorship; direct-to-consumer genetic carrier test authorized by FDA.
• January 2015
  Public health and clinical experts address HPV and prevention, and Q&A with Deborah Korenstein.
• November 2014
  Expanding SOAR studies outside of Manhattan, studying e-cigarette use, and an epidemiology forum planned for February 2015.
• September 2014
  MSK Transdisciplinary Population Science awards announced, new Survivorship Center established, and a discussion about universal screening for BRCA1 and BRCA2.
• May 2014
  Integrative Medicine Service studies complementary therapies, gene mutation associated with rare ovarian cancer, and a Q&A with surgeon Behfar Ehdaie.
• March 2014
  Five decades of tobacco research, control and public awareness, ASCO celebrates its 50th anniversary, and a Q&A with physiologist Lee Jones.
• January 2014
  Surveillance, Epidemiology, and End Results Program celebrates its 40th year, CCNY-MSKCC Partnership grant is renewed, Channel and Goldstein Grants awarded to Memorial Sloan Kettering investigators, and US Preventive Services Task Force finalized its recommendations for lung cancer screening.
• November 2013
  Memorial Sloan Kettering protects research resources and plans for the future, meeting address health disparities and needs in South Asian immigrant communities, and Institute of Medicine declares cancer care delivery system “in crisis”.
• September 2013
  Memorial Sloan Kettering symposium addresses challenges in genetic epidemiology, institutional biospecimen protocol amended to address new tests and incidental findings, and a Q&A with psychologist Jada Hamilton.
• May 2013
  Genomic analysis reveals endometrial cancer subtypes, new research council established for minimal risk studies, and a Q&A with health services researcher Yvonne Bombard.
• March 2013
  Federal budget cuts take effect, comments and advice from Colin Begg on the “grant game,” and ASCO issues a statement on survivorship care.
• December 2012
  Memorial Sloan Kettering group studies needs of immigrant and underserved communities in New York City, Supreme Court will decide whether human genes can be patented, and new funding opportunities in outcomes research.
• September 2012
  Guidelines discourage routine prostate cancer screening, SOAR Investigators successful despite challenging funding climate, and a Q&A with physician-scientist Sigrid Carlsson.
• July 2012
  A welcome message from Colin Begg, new guidelines for lung cancer screening, and SOAR faculty present at ASCO annual meetings.